• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Clarivate Plc

    3/28/25 8:15:32 AM ET
    $CLVT
    EDP Services
    Technology
    Get the next $CLVT alert in real time by email
    DEFA14A 1 tm255843d3_defa14a.htm DEFA14A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 14A

     

    Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

     

     

     

    Filed by the Registrant x Filed by a party other than the Registrant ¨

     

    Check the appropriate box:

     

    ¨Preliminary Proxy Statement

     

    ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ¨Definitive Proxy Statement
      
    xDefinitive Additional Materials

     

    ¨Soliciting Material Pursuant to Section 240.14a-12

     

    CLARIVATE PLC

    (Name of Registrant as Specified In Its Charter)

     

    n/a

    (Name of Person(s) Filing Proxy Statement if other than the Registrant)

     

    Payment of Filing Fee (Check all boxes that apply):

     

    xNo fee required.
      
    ¨Fee paid previously with preliminary materials.

     

    ¨Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11

     

     

     

     

     

    GRAPHIC

    Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V62776-P26893 CLARIVATE PLC 70 ST MARY AXE LONDON EC3A 8BE UNITED KINGDOM CLARIVATE PLC 2025 Annual General Meeting Vote by May 2, 2025 11:59 PM ET You invested in CLARIVATE PLC and it’s time to vote! You have the right to vote on proposals being presented at the Annual General Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 7, 2025. Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to April 23, 2025. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Vote in Person at the Meeting* May 7, 2025 1:00 PM BST/8:00 AM EDT Clarivate Plc 70 St Mary Axe London EC3A 8BE United Kingdom

    GRAPHIC

    Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V62777-P26893 Voting Items Board Recommends THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming shareholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. RE-ELECTION OF DIRECTORS Nominees: 1a. Andrew Snyder For 1b. Valeria Alberola For 1c. Jane Okun Bomba For 1d. Usama N. Cortas For 1e. Suzanne Heywood For 1f. Adam T. Levyn For 1g. Anthony Munk For 1h. Wendell Pritchett For 1i. Saurabh Saha For 1j. Matitiahu (Matti) Shem Tov For 2. APPROVAL, ON AN ADVISORY, NON-BINDING BASIS, OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. For 3. REAPPOINTMENT OF OUR AUDITORS, RATIFICATION OF THEIR APPOINTMENT AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS ON AN ADVISORY, NON-BINDING BASIS, AND AUTHORIZATION OF OUR BOARD OF DIRECTORS, ACTING THROUGH ITS AUDIT COMMITTEE, TO DETERMINE THE FEES TO BE PAID TO THE AUDITORS. For 4. APPROVAL OF THE CLARIVATE PLC AMENDED AND RESTATED 2019 INCENTIVE AWARD PLAN. For 5. AUTHORIZATION TO REPURCHASE THE COMPANY’S ORDINARY SHARES IN OPEN-MARKET TRANSACTIONS. For NOTE: In their discretion, the proxies are authorized to vote upon such other business as may properly come before the Annual General Meeting or any continuation, postponement or adjournment thereof.

    Get the next $CLVT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLVT

    DatePrice TargetRatingAnalyst
    11/6/2024Outperform → Mkt Perform
    William Blair
    12/15/2023$8.00Equal Weight → Underweight
    Wells Fargo
    10/16/2023$10.00 → $8.50Hold → Buy
    Jefferies
    9/8/2023$8.00 → $7.00Equal Weight → Underweight
    Barclays
    8/25/2023$9.00 → $8.00Outperform → Sector Perform
    RBC Capital Mkts
    8/7/2023$10.00 → $6.00Neutral → Underperform
    BofA Securities
    8/4/2023$15.00 → $8.00Overweight → Equal Weight
    Wells Fargo
    6/13/2023$11.00Outperform
    Oppenheimer
    More analyst ratings

    $CLVT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Clarivate Reports First Quarter 2025 Results

      — Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON, April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024. Organic revenues for the first quarter of 2025 increased 0.3%, compared to the first quarter of 202

      4/29/25 6:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Launches DRG Commercial Analytics 360 Enabling Medtech Companies to Advance Commercial Strategy and Execution

      New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations LONDON, April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG Commercial Analytics 360—a solution designed to empower medtech companies with advanced insights to drive commercial performance. As the demand for precise, analytics-driven strategies grows, medtech companies require deeper visibility into customer activity, affiliations, practice behavior and caseloads. DRG Commercial Analytics 360 equips commercial teams with the insig

      4/23/25 4:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Releases EndNote 2025 with AI-Powered Research Tools

      Enhancing research efficiency and accuracy with newly integrated features  LONDON, April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released EndNote 2025, a comprehensive reference management solution that streamlines the research and writing process. Its new features include AI support, enhanced referencing tools, and journal matching capabilities, designed to save researchers time and improve accuracy. Emmanuel Thiveaud, Senior Vice President, Research and Analytics, Academia & Government at Clarivate s

      4/23/25 3:00:00 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Clarivate downgraded by William Blair

      William Blair downgraded Clarivate from Outperform to Mkt Perform

      11/6/24 8:22:43 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded Clarivate from Equal Weight to Underweight and set a new price target of $8.00

      12/15/23 8:04:33 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate upgraded by Jefferies with a new price target

      Jefferies upgraded Clarivate from Hold to Buy and set a new price target of $8.50 from $10.00 previously

      10/16/23 9:11:50 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Financials

    Live finance-specific insights

    See more
    • Clarivate Reports First Quarter 2025 Results

      — Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON, April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024. Organic revenues for the first quarter of 2025 increased 0.3%, compared to the first quarter of 202

      4/29/25 6:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate to Report First Quarter 2025 Results on April 29, 2025

      LONDON, April 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter 2025 before the market opens on Tuesday, April 29, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Tuesday, April 29, 2025 to review the results. The webcast is open to all interested

      4/2/25 8:05:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Reports Fourth Quarter and Full Year 2024 Results

      — Accelerates transition from transactional to subscription and re-occurring revenue — — Launches new product innovation for Academia & Government and Life Sciences & Healthcare — — Repurchased $200 million ordinary shares and pre-paid $198 million of debt in 2024 as part of balanced capital allocation strategy — — Initiates review of strategic alternatives including potential divestitures — — Provides 2025 Outlook — LONDON, Feb. 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the fourth quarter and full year ended December 31, 2024.

      2/19/25 6:00:00 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Snyder Andrew Miles bought $989,024 worth of Ordinary Shares (237,176 units at $4.17) (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/18/25 4:56:10 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Bomba Jane L Okun bought $200,492 worth of Ordinary Shares (49,750 units at $4.03) (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/14/25 4:14:29 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Pritchett Wendell E. bought $100,114 worth of Ordinary Shares (22,857 units at $4.38), increasing direct ownership by 47% to 71,835 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/5/25 4:17:24 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Alberola Valeria was granted 39,473 units of Ordinary Shares and covered exercise/tax liability with 6,042 units of Ordinary Shares, increasing direct ownership by 58% to 91,158 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      5/8/25 9:02:45 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Saha Saurabh covered exercise/tax liability with 4,974 units of Ordinary Shares and was granted 39,473 units of Ordinary Shares, increasing direct ownership by 42% to 116,515 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      5/8/25 9:02:34 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Bomba Jane L Okun covered exercise/tax liability with 1,722 units of Ordinary Shares and was granted 39,473 units of Ordinary Shares, increasing direct ownership by 22% to 207,290 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      5/8/25 9:02:25 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Clarivate Plc

      SC 13G/A - CLARIVATE PLC (0001764046) (Subject)

      12/5/24 10:02:09 AM ET
      $CLVT
      EDP Services
      Technology
    • SEC Form SC 13G filed by Clarivate Plc

      SC 13G - CLARIVATE PLC (0001764046) (Subject)

      11/13/24 4:18:30 PM ET
      $CLVT
      EDP Services
      Technology
    • SEC Form SC 13D/A filed by Clarivate Plc (Amendment)

      SC 13D/A - CLARIVATE PLC (0001764046) (Subject)

      3/4/24 9:01:44 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Leadership Updates

    Live Leadership Updates

    See more
    • Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

      Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,

      4/26/23 7:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Names Bar Veinstein as President, Academia & Government

      Appointing the second of three business leaders for its newly created market segments LONDON, April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy. He previously spent 11 years with the Ex Libris Group, now part of Clarivate, and under his leader

      4/19/23 7:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director

      Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON, March 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.

      3/23/23 4:30:00 PM ET
      $CLVT
      $CNTA
      EDP Services
      Technology
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $CLVT
    SEC Filings

    See more
    • SEC Form 10-Q filed by Clarivate Plc

      10-Q - CLARIVATE PLC (0001764046) (Filer)

      4/29/25 6:03:43 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Plc filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CLARIVATE PLC (0001764046) (Filer)

      4/29/25 6:03:05 AM ET
      $CLVT
      EDP Services
      Technology
    • SEC Form DEFA14A filed by Clarivate Plc

      DEFA14A - CLARIVATE PLC (0001764046) (Filer)

      3/28/25 8:15:32 AM ET
      $CLVT
      EDP Services
      Technology